The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ionosol MB and Dextrose
DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 260 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; MAGNESIUM CHLORIDE 30 mg/100mL; MONOBASIC POTASSIUM PHOSPHATE 15 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 25 mg/100mL · Injection, Solution · Intravenous · ICU Medical Inc.
NDC 00990-7372-62 · 24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 250 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$9.80
Reported to Texas DSHS · 2026 annual filing · Otsuka ICU Medical LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA019513
- TE code
- —
- Approval date
- May 8, 1986
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| ICU Medical Inc. | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 260 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; MAGNESIUM CHLORIDE 30 mg/100mL; MONOBASIC POTASSIUM PHOSPHATE 15 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 25 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| ICU Medical Inc. | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM LACTATE 30 mg/100mL; POTASSIUM CHLORIDE 15 mg/100mL; MAGNESIUM CHLORIDE 141 mg/100mL; MONOBASIC POTASSIUM PHOSPHATE 260 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 25 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| ICU Medical Inc. | DEXTROSE MONOHYDRATE 5 g/100mL; MAGNESIUM CHLORIDE 30 mg/100mL; MONOBASIC POTASSIUM PHOSPHATE 15 mg/100mL; POTASSIUM CHLORIDE 141 mg/100mL; SODIUM LACTATE 260 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 25 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ionosol MB and Dextrose — NDC 00990-7372-62," retrieved September 3, 2026, https://drugdashboards.com/drug/00990737262.
Free to cite with attribution — see how the data is put together.